Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > Small molecules > alectinib
alectinib
Sunday 13 July 2014
Alectinib (Chugai, NDA has been filed in Japan) is an ALK inhibitor (WP).
D. Systemic pathology
- Immune system diseases
- Aging
- Endocrine systemic anomalies
- Environmental and occupational diseases
- Genetic and developmental anomalies
- Hematopathology
- Infectious diseases
- Nutritional diseases
-
Toxics and drugs
-
Therapeutics
- Targeted therapy
- Gene therapy
-
Therapeutics
- Vascular anomalies
